COVID-19

News

UK scientists trial Humira biosimilar for COVID-19 in care h...

Researchers at the University of Oxford in the UK have started a trial of TNF inhibitor adalimumab for COVID-19 patients in care homes and other community settings.

News

EMA review of AZ’s COVID-19 vaccine imminent; report

The EU regulator is poised to start a review of AstraZeneca and Oxford University’s COVID-19 vaccine, but the FDA is widening its investigation into the shot’s safety, according to reports

Partner Content

Partner Content

Fishawack Health, a new breed of global commercialization pa...

Fishawack Health has reorganized business operations as a leading global commercialization partner for the life-sciences industry.

Events

Partner Content

2nd Digital Exosome Based Therapeutic Development Summit

Advancing the Success of Exosome Therapeutics

Sales & Marketing

Gitte Aabo on telemedicine and GN Hearing: the pharmaphorum ...

Joining the pharmaphorum podcast for episode 24 is Gitte Aabo, who last year moved to hearing aid technology firm GN Hearing as CEO.

News

FDA slams brakes on Inovio's final-stage COVID-19 vaccine tr...

Inovio Pharma’s plan to start pivotal testing of its COVID-19 vaccine has been delayed by FDA requests for more information, sending its shares into a swift decline.

UK scientists trial Humira biosimilar for COVID-19 in care h...

EMA review of AZ’s COVID-19 vaccine imminent; report

Fishawack Health, a new breed of global commercialization pa...

2nd Digital Exosome Based Therapeutic Development Summit

Gitte Aabo on telemedicine and GN Hearing: the pharmaphorum ...

FDA slams brakes on Inovio's final-stage COVID-19 vaccine tr...

Beyond recruitment: Creating patient engagement that lasts

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks